I had been following GNE for a few years and got away from it. Obviously I'll do my own DD to get refreshed but could any of the longs here highlight concerns or aspirations they have at the moment for GNE? Exploration aside, I've always thought GNE had a good core business with dedicated management. But the freakishly powerful list of strategic advisors is what has kept my attention over the years.
Probably works for the FDA. It would explain the amount of free time he has.
When do you expect this will happen? I know the PR said the FDA has 360 days to do "review and action." In my experience they take their time, but I don't have experience with this action. Also, "review and action" doesn't sound like the FDA has to provide a definitive decision.
They don't have the data to attract a partner, IMO. If they did they would have partnered long ago. Prana has been churned up this same % several times and it was only trading, nothing material, and stock falls back in a short time. Yet every time, without fail, people read it as a positive catalyst coming. Like a broken clock, eventually you will be right, but be conscious of reality.